Letters
Brugada Syndrome and the Subcutaneous Implantable Cardioverter-Defibrillator

https://doi.org/10.1016/j.jacc.2016.05.058Get rights and content
Under an Elsevier user license
open archive

Cited by (0)

Please note: Dr. Regoli has received speaker’s fees from Medtronic and LivaNova. Dr. Auricchio has been a consultant to Medtronic, Boston Scientific, LivaNova, and St. Jude; and has received speaker’s fees from Medtronic, Boston Scientific, and LivaNova. Dr. Knops has received a research grant from Boston Scientific. All other authors have reported that they have no relationships relevant to the contents of this paper to disclose.

© 2016 by the American College of Cardiology Foundation